Breast Cancer and Cancer-Testis Antigens: A Potential Vaccine Target
Author Information
Author(s): Taylor Mark, Bolton Louise M, Johnson Peter, Elliott Tim, Murray Nick
Primary Institution: University of Southampton
Hypothesis
What is the frequency of expression of cancer-testis antigens (CTAGs) in breast cancer?
Conclusion
More than two-thirds of breast cancers would be covered by a vaccine directed against just three CTAGs.
Supporting Evidence
- 93% of tumours in the first series expressed at least one CTAG.
- 62% expressed the single antigen CTAG1.
- 80% of tumours in the second series expressed at least one CTAG.
Takeaway
Most breast cancers have special proteins called CTAGs that a vaccine could target to help the immune system fight the cancer.
Methodology
Breast tumours were collected and screened for expression of various CTAGs using cDNA analysis.
Limitations
The study did not analyze the HLA status of the individuals from whom the tumour specimens were derived.
Participant Demographics
Tumour samples were obtained from individuals undergoing surgery for primary invasive breast cancer.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website